MedTrace Logo

Preventing Violence Among Veterans in Substance Use Disorder Treatment

NCT01337973 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2019-09-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the impact on both clinical (violence and substance use) outcomes and health services use (substance use disorder and mental health treatment) compared to standard SUD treatment (enhanced treatment as usual) of

1. an integrated Motivational Interviewing-Cognitive Behavioral Therapy (MI-CBT) violence prevention treatment intervention delivered during the 8-week early substance use disorder treatment phase; and
2. MI-CBT plus a continuing care (CC) intervention for the 3-month continuing care period following the early treatment phase MI-CBT+CC).

The study will provide important new information regarding the role and relative impact of both early treatment and continuing care interventions designed to impact substance use and violence, and whether combining such interventions yields additional benefits.

Conditions

  • Aggression
  • Substance-Related Disorders

Interventions

BEHAVIORAL

MI-CBT

Six individual psychotherapy sessions during the acute substance use disorder treatment phase integrating motivational interviewing and cognitive behavioral approaches

BEHAVIORAL

MI-CBT+CC

Acute phase MI-CBT intervention plus a subsequent 12-week phone based continuing care counseling intervention

BEHAVIORAL

E-TAU

Enhanced Treatment as Usual

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Stephen T. Chermack, PhD MA BA · VA Ann Arbor Healthcare System, Ann Arbor, MI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-20
Primary Completion
2016-12-01
Completion
2017-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01337973 on ClinicalTrials.gov